Controlling Rapid Atrial Fibrillation With Dexmedetomidine

NCT04042727 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Futility, as a result of COVID-19 impact

Conditions

Rapid Atrial Fibrillation
Heart Rate Control

Interventions

DRUG: Dexmedetomidine Hydrochloride
OTHER: Normal Saline

Sponsor

Stony Brook University